BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 11739404)

  • 21. A naturally occurring allele of BRCA1 coding for a temperature-sensitive mutant protein.
    Worley T; Vallon-Christersson J; Billack B; Borg A; Monteiro AN
    Cancer Biol Ther; 2002; 1(5):497-501. PubMed ID: 12496476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter.
    Chai YL; Cui J; Shao N; Shyam E; Reddy P; Rao VN
    Oncogene; 1999 Jan; 18(1):263-8. PubMed ID: 9926942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
    Shiozaki EN; Gu L; Yan N; Shi Y
    Mol Cell; 2004 May; 14(3):405-12. PubMed ID: 15125843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis to characterise transactivation domain of BRCA1.
    Yadav LR; Biswal MN; Hosur MV; Kumar NS; Varma AK
    J Biomol Struct Dyn; 2017 Jan; 35(1):1-7. PubMed ID: 26727155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated microscopy identifies estrogen receptor subdomains with large-scale chromatin structure unfolding activity.
    Carpenter AE; Ashouri A; Belmont AS
    Cytometry A; 2004 Apr; 58(2):157-66. PubMed ID: 15057969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatin remodeling and activation of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1.
    Hu YF; Hao ZL; Li R
    Genes Dev; 1999 Mar; 13(6):637-42. PubMed ID: 10090719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
    Gough CA; Gojobori T; Imanishi T
    Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the BRCT binding site of BRCA1 result in hyper-recombination.
    Dever SM; Golding SE; Rosenberg E; Adams BR; Idowu MO; Quillin JM; Valerie N; Xu B; Povirk LF; Valerie K
    Aging (Albany NY); 2011 May; 3(5):515-32. PubMed ID: 21666281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel domain of BRCA1 interacts with p53 in breast cancer cells.
    Buck M
    Cancer Lett; 2008 Sep; 268(1):137-45. PubMed ID: 18501503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concerted transcriptional regulation by BRCA1 and COBRA1 in breast cancer cells.
    Aiyar SE; Cho H; Lee J; Li R
    Int J Biol Sci; 2007 Nov; 3(7):486-92. PubMed ID: 18071589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between BRCT repeats and phosphoproteins: tangled up in two.
    Glover JN; Williams RS; Lee MS
    Trends Biochem Sci; 2004 Nov; 29(11):579-85. PubMed ID: 15501676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A structural bioinformatics approach to explore the interactions of P53 and BRCA1 gene products on ovarian and breast cancer.
    Parija S; Kumar A
    Int J Bioinform Res Appl; 2011; 7(1):1-14. PubMed ID: 21441093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.
    Joo WS; Jeffrey PD; Cantor SB; Finnin MS; Livingston DM; Pavletich NP
    Genes Dev; 2002 Mar; 16(5):583-93. PubMed ID: 11877378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
    Tischkowitz M; Hamel N; Carvalho MA; Birrane G; Soni A; van Beers EH; Joosse SA; Wong N; Novak D; Quenneville LA; Grist SA; ; Nederlof PM; Goldgar DE; Tavtigian SV; Monteiro AN; Ladias JA; Foulkes WD
    Eur J Hum Genet; 2008 Jul; 16(7):820-32. PubMed ID: 18285836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An hGCN5/TRRAP histone acetyltransferase complex co-activates BRCA1 transactivation function through histone modification.
    Oishi H; Kitagawa H; Wada O; Takezawa S; Tora L; Kouzu-Fujita M; Takada I; Yano T; Yanagisawa J; Kato S
    J Biol Chem; 2006 Jan; 281(1):20-6. PubMed ID: 16260778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.
    Williams RS; Glover JN
    J Biol Chem; 2003 Jan; 278(4):2630-5. PubMed ID: 12427738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220.
    Wada O; Oishi H; Takada I; Yanagisawa J; Yano T; Kato S
    Oncogene; 2004 Aug; 23(35):6000-5. PubMed ID: 15208681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCA1 interacts with components of the histone deacetylase complex.
    Yarden RI; Brody LC
    Proc Natl Acad Sci U S A; 1999 Apr; 96(9):4983-8. PubMed ID: 10220405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS; Lee MS; Hau DD; Glover JN
    Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of COBRA1 in human breast cancer cell lines using a new polyclonal antibody against COBRA1.
    Zhu J; Song S; Jiang Z; Yan J; Lu Q; Huang C; Ye Q
    IUBMB Life; 2004 Mar; 56(3):161-6. PubMed ID: 15185750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.